now browsing by category
The Cancer Treatment Centers of America is currently working with Allscripts and NantHealth to create a custom solution to integrate cancer care data and health records without disturbing the physician’s workflow. The platform will provide the oncologist with custom treatment regimens that are tailored specifically to the patient and their specific cancer. They have the ability to input data entry by tapping the screen for more efficiency. The platform supports clinical data and real-time functionality.
The integrated program helps improve the patients quality of life and care. Doctors and patients can compare treatment options with great confidence. The library includes an extensive amount of information from peer-reviewed government agencies, literature and oncology associations. Once the physician has selected a proper regimen, they can easily access the Allscripts’ platform for quick data entry.
The Cancer Treatment Centers of America is based in Boca Raton, FL. There are five hospitals across the nation dedicated to finding cure for all cancers. They are located in Tulsa, Philadelphia, Atlanta, Phoenix and Chicago. These hospitals combine the advancements in care with treatment and genomic testing. Their progressive testing has improved ones quality of life while managing side effects. They deliver quality care and provide the families with the latest information about their treatment options.
Everyone’s cancer is different and requires treatment plan that is tailored to your specific needs. The experts at Cancer Treatment Centers of America work with you and other clinicians to diagnose your unique situation. They use state-of-the-art technology to help you manage pain, fatigue and neuropathy.
Prostate cancer is the most common form of cancer found in men and can be spotted in those aged over 40 using the simple to administer Prostate Specific Antigen test. The Cancer Treatment Centers of America has partnered with the National Football League Alumni association and LabCorp to try and raise awareness of the medical condition alongside offering a special discount for prostate cancer screening; the first 2,000 men over 40 applying for the Prostate Specific Antigen test will not be charged and those who follow will receive screening for the discounted cost of just $25.
The Cancer Treatment Centers of America has been looking for different ways of raising awareness of prostate cancer among men above the age of 40 and is now working with former head coaches from the NFL. Prostate cancer awareness month will be the time when public service announcements featuring some of the most popular former head coaches of recent years will air to assist in raising awareness about this commonly seen form of cancer. Those who have a family history of prostate cancer and from specific racial groups have an increased risk of being diagnosed with this form of cancer.
Finding success in the healthcare industry has been completed in just three decades by the Cancer Treatment Centers of America which has seen four of its five facilities awarded five-star ratings from U.S. Centers for Medicaid and Medicare Services. A number of other leading healthcare service providers have also praised the Cancer Treatment Centers of America for their excellent service including the Association of Community Cancer Centers.
The success seen in the U.S. by the Cancer Treatment Centers of America has seen the cancer treatment provider develop its presence across much of the Middle East and portions of South and Central America.
Visit More : www.myctca.com
The fight against cancer is still ongoing within the Canter Treatment Centers of America camp. Everyday, this cancer care organization sees or hears of new cancer diagnoses. Striving to offer a bright beacon of shining optimistic hope, the centers are moving full speed ahead with their cancer care and cure plans. An interesting new clinical pathway is allowing this giant organization to better communicate important cancer facts, treatments, recommended treatment options and medication side effects. This information and more is now stored on this data server that is easily accessed by CTCA staff and cancer patients. They aren’t giving up on their cancer obliteration dream.
Many adults with cancer prefer the intimate and whole body, soul, mind and spirit healthcare offered through CTCA. Patients work with nutritionists to finds ways of maintaining weight during vigorous and draining cancer treatments like chemotherapy and/or radiation treatments. Patients are supported emotionally and mentally with ready counselors and trained therapists able to help. Every patient is encouraged to nourish their souls and spirits, either by praying, attending church service, celebrating life and appreciating the smaller joys of life. Unbeatable cancer treatments are given in completely individualized patient treatment regimens. No detail is too small for this big and compassionate healthcare organization.
Cancer Treatment Centers of America are grateful that many of their patients are surviving this insidious disease. More ordinary people are joining this horrific fight to save lives. Families of patients find a warm and welcoming place in these centers. The staff understands how cancer can affect many family members who are trying to remain strong too. As hard as cancer is, CTCA is fighting back harder. Every new treatment option allows increased chances of recovery and survival. The people afflicted are the reason why these heroic staff members keep going everyday.
We live at a time when medical breakthroughs are being made almost weekly. The fight against all forms of cancer is being taken on by many pharmaceutical companies. The treatment methodology has added targeted chemotherapy to the basic treatment of radiation and traditional chemotherapy. These exciting new therapies may, in the not too distant future, provide ways to treat and possibly cure many types of cancer.
One such company making huge strides in cancer treatment is Seattle Genetics. Founded in 1998, its CEO Dr. Clay Siegall has driven his company to excel in new technology. Dr. Siegal is driven by an intense desire to help cancer patients and has made it a priority for his company to concentrate on research and quickly implement any medical breakthroughs.
Dr, Siegall worked for the National Cancer Institute from 1988 to 1991, and then became a Senior Research Investigator for Bristol-Myers Squibb. He soon was promoted to Principal Scientist, and then became a Staff Fellow and Biotechnology Fellow at the National Cancer Institute. In addition to leading Seattle Genetics, Dr. Siegall has more than 70 published scientific articles and 15 patents to his credit.
Under his tutelage, in 2011 the company received FDA approval for the first antibody-drug conjugate (ADCs) ADCETRIS and is now available to patients in 60 countries. In 2016, the FDA granted Breakthrough Therapy Designation for another antibody-drug conjugate, sacituzumab govitecan (try saying that three times fast). This wonder drug is being tested for treatment of a number of cancers, including lung, breast, bladder and pancreatic cancer.
With many new antibody-based cancer therapies in their pipeline, Dr. Siegall may soon realize his dream of conquering cancer.
As one would know, there are many different types of cancer that one can come down with. Some of them have an effect on men only, or women only. Then there are the types of cancer that can affect both genders evenly. However, it may be surprising to know the many different types of cancer that one can get. However, as one learns about the different forms of cancer, they will also learn about the risk factors involves and the ways to prevent it. The best way to learn about this is through information gathered from a good source that is exhaustive in information about cancer.
According to Wikipedia, one good source of information that people can go to is Cancer Treatment Centers of America. There are tons of different types of cancer that are listed on the site. One good thing about this company is that if there are any new discoveries in the cancer realm, this is one of the first sites to upload this information. Cancer Treatment Centers of America does not waste any time when it comes to handling cancer. They understand that time is of the essence for people who have this condition because they could eventually die from the cancer.
Among the different forms of cancer that people can be affected with are brain cancer, leukemia, breast cancer, bladder cancer, prostate cancer, and plenty of other forms of cancer. Some of the forms of cancer are harder to treat than others. One reason is that they are hard to detect. Fortunately, Cancer Treatment Centers of America is willing to help with the avoidance of cancer as well because they understand that even the treatment of cancer can be very devastating to the individual. Chemotherapy does cause a lot of issue in the body that needs to be treated with other medications.
For more information on CTCA follow them on Facebook.
There are a lot of issues that come with cancer. One thing that people who have gained cancer are going to be faced with are a ton of issues. For one thing, people are going to have a lot of questions. However, they may not be able to ask it all at once because the news that they have cancer can come as a serious blow to their way of life. Fortunately, there is a place where they could get answers. This place is called Cancer Treatment Centers of America. This place is the one database that contains information not only about cancer, but also the treatment.
According to the article, “Cancer Treatment Centers of America® Partners with Allscripts and NantHealth to Launch Clinical Pathways, a Comprehensive and Custom Oncology Treatment Platform,” CTCA also offers people many options for care as they go through the different stages. Of course when they are given the diagnosis, they are going to want to know what they are looking at. With CTCA, they are able to get all of the information of what could possibly happen. For instance, they may get information as to if they are going to need surgery after chemotherapy. At the same time, the professionals at Cancer Treatment Centers of America are willing to find someone with the answers if they themselves do not have the answers that are needed.
CCA has proven itself to be one of the powerhouses of cancer treatment. This is one of the reasons that many other medical facilities and institutions are willing to team up with CTCA. Among the partnerships that CTCA has formed are those with NantHealth and AllScripts. Therefore, they will get even more assistance with finding more effective treatments for cancer. People will also be able to do some research for themselves on the disease that is affecting many people in the world. For those that do not have cancer yet, there are things that can be done to prevent the occurrence of the disease.
At the helm of the leading innovative, antibody-drug conjugates biotechnology firm in the nation, is Clay B. Siegall, Ph.D. Siegall co-founded Seattle Genetics in 1998. Aside from the title of President, he also holds the positions of Chairman of the Board and Chief Executive Officer.
The focus of Seattle Genetics is on cancer antibody treatments and therapies. The treatments and therapies, known as antibody-drug conjugates (ADCs). ADC’s captures a monoclonal antibody’s targeting mechanism and produces producing cancer destroying elements to cells afflicted with cancer. ADC’s target only cancer cells and avoid non-cancerous cells. This process dramatically lowers the toxicity from chemotherapy and possibly enhances anti-tumor development. Seattle Genetics innovative technology fulfills the need for life-threatening solutions.
CEO, President, and Chairman of the Board, Clay B. Siegall career trained him as a scientist. His curiosity with a cure for cancer leads him to form Seattle Genetics. Seattle Genetics dedication towards contemporary innovation, determined research, and pharmaceutical drug development makes it a leader in the cancer biotechnology sector.
Dr.Siegall spearheaded Seattle Genetic’s successful 2011 effort in obtaining the United States Food and Drug Administration’s approval of ADCETRIS® (brentuximab vedotin). He worked closely with the Takeda Pharmaceutical Company, overseeing a joint marketing agreement and distribution effort. The agreement makes ADCETRIS the leading brand worldwide for cancer treatments. So successful is the product, 60 governmental authorities around the world have approved its use. As a result of its success, Seattle Genetics is establishing a vast array of proprietary ADC cancer treatments.
Seattle Genetic’s success in research technology of ADC’s enabled it to sign numerous strategic production and marketing licenses with Pfizer, Genentech (Roche), GlaxoSmithKline and AbbVie. These collaborative agreements brought Seattle Genetics over $325 million. With over 20 ADC’s in development, Dr. Siegall’s efforts have increased the firm’s capital income, securing more than $1.2 billion in public offerings and private and public solicitations.
More information about Dr. Clay B. Siegall, Ph.D. and Seattle Genetics is available at their website, http://www.seattlegenetics.com/